Cargando…

Cytokine activity in Parkinson’s disease

The contribution of the immune system to the pathophysiology of neurodegenerative Parkinson’s disease (PD) is increasingly being recognised, with alterations in the innate and adaptive arms of the immune system underlying central and peripheral inflammation in PD. As chief modulators of the immune r...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dzamko, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695743/ http://dx.doi.org/10.1042/NS20220063

Ejemplares similares

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

Parkinson’s progression prediction using machine learning and serum cytokines
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2019)

Investigating lymphocyte populations in patients with Parkinson’s disease
por: Dzamko, Nicolas
Publicado: (2020)

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
por: Galper, Jasmin, et al.
Publicado: (2021)

Editorial: Updates on inflammation in Parkinson's disease
por: Dzamko, Nicolas, et al.
Publicado: (2023)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm, Farzaneh, et al.
Publicado: (2016)

WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes
por: Wallings, Rebecca L., et al.
Publicado: (2022)

LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Leucine Rich Repeat Kinase 2 and Innate Immunity
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2020)

Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
por: Farmer, Kyle, et al.
Publicado: (2015)

Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018)

Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
por: Youssef, Priscilla, et al.
Publicado: (2021)

Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
por: Atashrazm, Farzaneh, et al.
Publicado: (2018)

Evidence for Peripheral Immune Activation in Parkinson’s Disease
por: Chen, Xueping, et al.
Publicado: (2021)

Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity
por: Hughes, Laura P., et al.
Publicado: (2021)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
por: Labrador-Garrido, Adahir, et al.
Publicado: (2023)

Contribution of Pro-inflammatory Cytokine Signaling within Midbrain Periaqueductal Gray to Pain Sensitivity in Parkinson’s Disease via GABAergic Pathway
por: Zhuang, Xianbo, et al.
Publicado: (2016)

Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2022)

Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson’s disease
por: Cabré, Sílvia, et al.
Publicado: (2021)

Cognitive, Emotional, and Auto-Activation Dimensions of Apathy in Parkinson's Disease
por: Del-Monte, Jonathan, et al.
Publicado: (2017)

Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson’s Disease
por: Harrington, Deborah L., et al.
Publicado: (2017)

Abnormal Spontaneous Neural Activity in Parkinson’s Disease With “pure” Apathy
por: Sun, Hai-Hua, et al.
Publicado: (2020)

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
por: Shim, Kyu Hwan, et al.
Publicado: (2021)

Noradrenaline and Parkinson's Disease
por: Delaville, Claire, et al.
Publicado: (2011)

Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
por: Marsili, Luca, et al.
Publicado: (2018)

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
por: Subramaniam, Sudhakar R., et al.
Publicado: (2017)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
por: Shim, Kyu Hwan, et al.
Publicado: (2021)

Differential dopaminergic modulation of spontaneous cortico–subthalamic activity in Parkinson’s disease
por: Sharma, Abhinav, et al.
Publicado: (2021)

Abnormal brain activities in multiple frequency bands in Parkinson’s disease with apathy
por: Xu, Haikun, et al.
Publicado: (2022)

Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients
por: Bhumkar, Akshay, et al.
Publicado: (2021)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Parkinson’s Disease: No Milk Today?
por: Kistner, Andrea, et al.
Publicado: (2014)

Ganglioside Metabolism and Parkinson's Disease
por: Forsayeth, John, et al.
Publicado: (2018)

Parkinson Disease: An Evolutionary Perspective
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2017)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Targeting the inflammasome in Parkinson’s disease
por: Su, Qi, et al.
Publicado: (2022)

Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology
por: Dzamko, Nicolas, et al.
Publicado: (2016)

Poorer Cognitive Performance in Patients with Essential Tremor-Parkinson’s Disease vs. Patients with Parkinson’s Disease
por: Louis, Elan D., et al.
Publicado: (2015)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8kfo3v2kroat219bnc2u356hr8